[1] |
应佳栩,丘文,林慧娴,等.节律基因与肿瘤相关性研究进展[J].中国肿瘤,2019,28(12):927-933.
|
[2] |
Morales-Santana S,Morell S,Leon J,et al. An overview of the polymorphisms of circadian genes associated with endocrine cancer[J]. Front Endocrinol (Lausanne),2019,10:104.
|
[3] |
Takahashi JS.Transcriptional architecture of the mammalian circadian clock[J].Nat Rev Genet,2017,18(3):164-179.
|
[4] |
Sulli G,Manoogian ENC,Taub PR,et al.Training the circadian clock,clocking the drugs,and drugging the clock to prevent,manage,and treat chronic diseases[J].Trends Pharmacol Sci,2018,39(9):812-827.
|
[5] |
Deng F,Yang K.Current status of research on the period family of clock genes in the occurrence and development of cancer[J].J Cancer,2019,10(5):1117-1123.
|
[6] |
Zhao Q,Zheng G,Yang K,et al.The clock gene PER1 plays an important role in regulating the clock gene network in human oral squamous cell carcinoma cells[J].Oncotarget,2016,7(43):70 290-70 302.
|
[7] |
Battaglin F,Chan P,Pan Y,et al.Clocking cancer: the circadian clock as a target in cancer therapy[J].Oncogene,2021,40(18):3187-3200.
|
[8] |
Cao X,Yang Y,Selby CP,et al.Molecular mechanism of the repressive phase of the mammalian circadian clock[J].Proc Natl Acad Sci USA,2021,118(2):e2021174118.
|
[9] |
Gaucher J,Montellier E,Sassone-orsi P. Molecular cogs: interplay between circadian clock and cell cycle[J].Trends Cell Biol,2018,28(5):368-379.
|
[10] |
Luciano AK,Zhou W,Santana JM,et al.Clock phosphorylation by AKT regulates its nuclear accumulation and circadian gene expression in peripheral tissues[J].J Biol Chem,2018,293(23):9126-9136.
|
[11] |
Saran AR,Kalinowska D,Oh S,et al.JMJD5 links CRY1 function and proteasomal degradation[J].PLoS Biol,2018,16(11):e2006145.
|
[12] |
Liu N,Zhang EE.Phosphorylation regulating the ratio of intracellular CRY1 protein determines the circadian period[J].Front Neurol,2016,7:1159.
|
[13] |
Tamaru T,Hirayama J,Isojima Y,et al.CK2alpha phosphorylates BMAL1 to regulate the mammalian clock[J].Nat Struct Mol Biol,2009,16(4):446-448.
|
[14] |
Tsuchiya Y,Akashi M,Matsuda M,et al.Involvement of the protein kinase CK2 in the regulation of mammalian circadian rhythms[J].Sci Signal,2009,2(73):26.
|
[15] |
Liu Y,Hao J,Yuan G,et al.PER1 as a tumor suppressor attenuated in the malignant phenotypes of breast cancer cells[J].Int J Gen Med,2021,14:7077-7087.
|
[16] |
Hwang-Verslues WW,Chang PH,Jeng YM,et al.Loss of corepressor PER2 under hypoxia up-regulates OCT1-mediated EMT gene expression and enhances tumor malignancy[J].Proc Natl Acad Sci USA,2013,110(30):12 331-12 336.
|
[17] |
Zhao H,Zeng ZL,Yang J,et al.Prognostic relevance of period1 (Per1) and period2 (Per2) expression in human gastric cancer[J].Int J Clin Exp Pathol,2014,7(2):619-630.
|
[18] |
Hernandez-Rosas F,Hernandez-Oliveras A,Flores-Peredo L,et al.Histone deacetylase inhibitors induce the expression of tumor suppressor genes Per1 and Per2 in human gastric cancer cells[J].Oncol Lett,2018,16(2):1981-1990.
|
[19] |
Tavano F,Pazienza V,Fontana A,et al.SIRT1 and circadian gene expression in pancreatic ductal adenocarcinoma: effect of starvation[J].Chronobiol Int,2015,32(4):497-512.
|
[20] |
Hasakova K,Reis R,Vician M,et al.Expression of miR-34a-5p is up-regulated in human colorectal cancer and correlates with survival and clock gene PER2 expression[J].PLoS One,2019,14(10):e0224396.
|
[21] |
Wang X,Yan D,Teng M,et al.Reduced expression of PER3 is associated with incidence and development of colon cancer[J].Ann Surg Oncol,2012,19(9):3081-3088.
|
[22] |
Wang Y,Cheng Y,Yu G,et al.Expression of PER, CRY, and TIM genes for the pathological features of colorectal cancer patients[J].Onco Targets Ther,2016,9:1997-2005.
|
[23] |
Oshima T,Takenoshita S,Akaike M,et al.Expression of circadian genes correlates with liver metastasis and outcomes in colorectal cancer[J].Oncol Rep,2011,25(5):1439-1446.
|
[24] |
Xiong H,Yang Y,Yang K,et al.Loss of the clock gene PER2 is associated with cancer development and altered expression of important tumor-related genes in oral cancer[J].Int J Oncol,2018,52(1):279-287.
|
[25] |
Hsu CM,Lin SF,Lu CT,et al.Altered expression of circadian clock genes in head and neck squamous cell carcinoma[J].Tumour Biol,2012,33(1):149-155.
|
[26] |
Liu B,Xu K,Jiang Y,et al.Aberrant expression of Per1,Per2 and Per3 and their prognostic relevance in non-small cell lung cancer[J].Int J Clin Exp Pathol,2014,7(11):7863-7871.
|
[27] |
Xiang R,Cui Y,Wang Y,et al.Circadian clock gene Per2 downregulation in nonsmall cell lung cancer is associated with tumour progression and metastasis[J].Oncol Rep,2018,40(5):3040-3048.
|
[28] |
Cao Q,Gery S,Dashti A,et al.A role for the clock gene per1 in prostate cancer[J].Cancer Res,2009,69(19):7619-7625.
|
[29] |
Li Q,Xia D,Wang Z,et al.Circadian rhythm gene PER3 negatively regulates stemness of prostate cancer stem cells via WNT/beta-Catenin Signaling in tumor microenvironment[J].Front Cell Dev Biol,2021,9:656 981.
|
[30] |
Wang Z,Wang H,Wang Z,et al.Associated analysis of PER1/TUBB2B with endometrial cancer development caused by circadian rhythm disorders[J].Med Oncol,2020,37(10):90.
|
[31] |
Chen M,Zhang L,Liu X,et al.PER1 is a prognostic biomarker and correlated with immune infiltrates in ovarian cancer[J].Front Genet,2021,12:697471.
|
[32] |
Zhanfeng N,Yanhui L,Zhou F,et al.Circadian genes Per1 and Per2 increase radiosensitivity of glioma in vivo[J].Oncotarget,2015,6(12):9951-9958.
|
[33] |
Ye H,Yang K,Tan XM,et al.Daily rhythm variations of the clock gene PER1 and cancer-related genes during various stages of carcinogenesis in a golden hamster model of buccal mucosa carcinoma[J].Onco Targets Ther,2015,8:1419-1426.
|
[34] |
Tan XM,Ye H,Yang K,et al.Circadian variations of clock gene Per2 and cell cycle genes in different stages of carcinogenesis in golden hamster buccal mucosa[J].Sci Rep,2015,5:9997.
|
[35] |
Han Y,Meng F,Venter J,et al.miR-34a-dependent overexpression of Per1 decreases cholangiocarcinoma growth[J].J Hepatol,2016,64(6):1295-1304.
|
[36] |
Mteyrek A,Filipski E,Guettier C,et al.Clock gene Per2 as a controller of liver carcinogenesis[J].Oncotarget,2016,7(52):85 832-85 847.
|
[37] |
De A,Beligala DH,Sharma VP,et al.Cancer stem cell generation during epithelial-mesenchymal transition is temporally gated by intrinsic circadian clocks[J].Clin Exp Metastasis,2020,37(5):617-635.
|
[38] |
Yang C,Wu J,Liu X,et al.Circadian rhythm is disrupted by ZNF704 in breast carcinogenesis[J].Cancer Res,2020,80(19):4114-4128.
|
[39] |
Alam H,Tang M,Maitituoheti M,et al.KMT2D deficiency impairs super-enhancers to confer a glycolytic vulnerability in lung cancer[J].Cancer Cell,2020,37(4):599-617.
|
[40] |
Mocellin S,Tropea S,Benna C,et al.Circadian pathway genetic variation and cancer risk: evidence from genome-wide association studies[J].BMC Med,2018,16(1):20.
|
[41] |
Lesicka M,Jablonska E,Wieczorek E,et al.Circadian gene polymorphisms associated with breast cancer susceptibility[J].Int J Mol Sci,2019,20(22):5704.
|
[42] |
Dagmura H,Yigit S,Nursal AF,et al.Possible association of PER2/PER3 variable number tandem repeat polymorphism variants with susceptibility and clinical characteristics in pancreatic cancer[J].Genet Test Mol Biomarkers,2021,25(2):124-130.
|
[43] |
Fu XJ,Li HX,Yang K,et al.The important tumor suppressor role of PER1 in regulating the cyclin-CDK-CKI network in SCC15 human oral squamous cell carcinoma cells[J].Onco Targets Ther,2016,9:2237-2245.
|
[44] |
Cheng AY,Zhang Y,Mei HJ,et al.Construction of a plasmid for overexpression of human circadian gene period2 and its biological activity in osteosarcoma cells[J].Tumour Biol,2015,36(5):3735-3743.
|
[45] |
Guo X,Li K,Jiang W,et al.RNA demethylase ALKBH5 prevents pancreatic cancer progression by posttranscriptional activation of PER1 in an m6A-YTHDF2-dependent manner[J].Mol Cancer,2020,19(1):91.
|
[46] |
Li HX,Fu XJ,Yang K,et al.The clock gene PER1 suppresses expression of tumor-related genes in human oral squamous cell carcinoma[J].Oncotarget,2016,7(15):20 574-20 583.
|
[47] |
Wang Z,Li L,Wang Y.Effects of Per2 overexpression on growth inhibition and metastasis,and on MTA1 nm23-H1 and the autophagy-associated PI3K/PKB signaling pathway in nude mice xenograft models of ovarian cancer[J].Mol Med Rep,2016,13(6):4561-4568.
|
[48] |
Zhanfeng N,Chengquan W,Hechun X,et al.Period2 downregulation inhibits glioma cell apoptosis by activating the MDM2-TP53 pathway[J].Oncotarget,2016,7(19):27 350-27 362.
|
[49] |
Gong X,Tang H,Yang K.PER1 suppresses glycolysis and cell proliferation in oral squamous cell carcinoma via the PER1/RACK1/PI3K signaling complex[J].Cell Death Dis,2021,12(3):276.
|
[50] |
Papagiannakopoulos T,Bauer MR,Davidson SM,et al.Circadian rhythm disruption promotes lung tumorigenesis[J].Cell Metab,2016,24(2):324-331.
|
[51] |
Schroll MM,LaBonia GJ,Ludwig KR,et al.Glucose restriction combined with autophagy inhibition and chemotherapy in HCT116 spheroids decreases cell clonogenicity and viability regulated by tumor suppressor genes[J].J Proteome Res,2017,16(8):3009-3018.
|
[52] |
Park H,Saravanakumar G,Kim J,et al.Tumor microenvironment sensitive nanocarriers for bioimaging and therapeutics[J].Adv Healthc Mater,2021,10(5):e2000834.
|
[53] |
Zhang Z,Zeng P,Gao W,et al.Circadian clock: a regulator of the immunity in cancer[J].Cell Commun Signal,2021,19(1):37.
|
[54] |
Xu H,Li H,Woo SL,et al.Myeloid cell-specific disruption of period1 and period2 exacerbates diet-induced inflammation and insulin resistance[J].J Biol Chem,2014,289(23):16374-16388.
|
[55] |
Wu Y,Tao B,Zhang T,et al.Pan-Cancer analysis reveals disrupted circadian clock associates with T cell exhaustion[J].Front Immunol,2019,10:2451.
|
[56] |
Wei W,Zhao W,Zhang Y.CBX4 provides an alternate mode of colon cancer development via potential influences on circadian rhythm and immune infiltration[J].Front Cell Dev Biol,2021,9:669 254.
|
[57] |
Bellet MM,Stincardini C,Costantini C,et al.The circadian protein PER1 modulates the cellular response to anticancer treatments[J].Int J Mol Sci,2021,22(6):2974.
|
[58] |
Wang Z,Li F,Wei M,et al.Circadian clock protein PERIOD2 suppresses the PI3K/Akt pathway and promotes cisplatin sensitivity in ovarian cancer[J].Cancer Manag Res,2020,12:11 897-11 908.
|
[59] |
Wang Z,Li F,He S,et al.Period circadian regulator 2 suppresses drug resistance to cisplatin by PI3K/AKT pathway and improves chronochemotherapeutic efficacy in cervical cancer[J].Gene,2022,809:146 003.
|
[60] |
Huang Z,He A,Wang J,et al.The circadian clock is associated with prognosis and immune infiltration in stomach adenocarcinoma[J].Aging (Albany NY),2021,13(12):16 637-16 655.
|
[61] |
Cai DW,Chen D,Sun SP,et al.Overexpression of PER3 reverses paclitaxel resistance of prostate cancer cells by inhibiting the Notch pathway[J].Eur Rev Med Pharmacol Sci,2018,22(9):2572-2579.
|
[62] |
Song S,Lei L,Zhang R,et al.Circadian disruption and breast cancer risk: evidence from a case-control study in china[J].Cancers (Basel),2023,15(2):419.
|
[63] |
Yang T,Huang W,Ma T,et al.The PRMT6/PARP1/CRL4B complex regulates the circadian clock and promotes breast tumorigenesis[J].Adv Sci (Weinh),2023,10(14):e2202737.
|
[64] |
Webb AJ,Harper E,Rattay T,et al.Treatment time and circadian genotype interact to influence radiotherapy side-effects. A prospective European validation study using the REQUITE cohort[J].EBioMedicine,2022,84:104269.
|